Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kansas City Proton Institute (KCPI) is a specialized cancer treatment facility located in Overland Park, Kansas, dedicated to providing advanced proton therapy. As a physician-led center, it utilizes state-of-the-art pencil beam scanning technology to deliver highly precise radiation doses that target tumors while sparing adjacent healthy organs and tissues. The institute treats a broad spectrum of adult and pediatric malignancies, including complex cases of the brain, spine, and prostate. By offering this non-invasive treatment modality, KCPI aims to reduce side effects and improve the long-term quality of life for cancer patients in the Midwest region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kansas City Proton Institute.